baber/WOPTO huggingface dataset:
Patent AU-2014200671-A1 (AU)
Title: Terahertz pulse radiation in treating skin disorders
Inventor: TITOVA LYUBOV
IPC: A61N5/00
Filed: 2014-02-07
Abstract: The invention provides methods for the treatment of skin disorders through the use of 5 minimally invasive non-ionizing terahertz radiation. The method includes providing a source of non-ionizing terahertz radiation and exposing skin cells to the non-ionizing terahertz radiation in amount sufficient to modulate gene expression in the skin cells. The modulation of gene expression then results in a reduction of the disease state in the exposed skin cells. 2013-061
Patent AU-2014201039-A1 (AU)
Title: Downlight assembly
Inventor: FARMER MICHAEL
IPC: F21V17/02
Filed: 2014-02-27
Abstract: Abstract The present invention relates to a mounting assembly for a downlight. The mounting assembly has a first configuration for satisfying a first installation requirement for the downlight. The mounting assembly is reconfigurable to have a second configuration for satisfying a second installation requirement for the downlight. Figure 4
Patent AU-2014202687-A1 (AU)
Title: Combination formulation of two antiviral compounds
Inventor: CHAL BEN
IPC: A61K31/00
Filed: 2014-01-30
Abstract: Attorney Docket No.: 37JD-191567-WO Disclosed are pharmaceutical compositions having an effective amount of substantially amorphous ledipasvir and an effective amount of substantially crystalline sofosbuvir.
Patent AU-2014202803-A1 (AU)
Title: Medical spraying device with nozzle, and method for producing a spray cone
Inventor: VOGT SEBASTIAN
IPC: A61M3/00
Filed: 2014-05-22
Abstract: MEDICAL SPRAYING DEVICE WITH NOZZLE, AND METHOD FOR PRODUCING A SPRAY Abstract A medical spraying device for irrigating a wound, in particular lavage system, comprises a liquid reservoir (16) for a medical irrigation liquid (18) or a connection for such a liquid reservoir (16) and an arrangement for applying pressure to the medical irrigation liquid (18), such that the irrigation liquid (18) can be pushed through a nozzle (24, 52) by the pressure acting on the irrigation liquid (18) in order to produce a spray cone (58), wherein the nozzle (24, 52) has a plurality of openings, which are arranged at an angle to one another in such a way that the irrigation liquid jets exiting from the openings meet in an atomisation space (38, 57) and/or a discharge opening of the nozzle (24, 52) and thus produce the spray cone (58) from the atomised irrigation liquid (18). Also provided is a method for producing a spray cone (58) of a medical irrigation liquid (18), in particular using a spraying device according to one of Claims 1 to 16, in which the irrigation liquid (18) is pushed through a plurality of openings in a nozzle (24, 52) and the irrigation liquid jets thus produced are shot towards one another at such a flow rate and at such an angle that the irrigation liquid jets atomise in front of the nozzle (24, 52) and form a spray cone (58). 38 36 34 30 26 9 15 14 12 10 9 8 1 2 4 6 Figure 1
Patent AU-2014203070-A1 (AU)
Title: High hardness, high toughness iron-base alloys and methods for making same
Inventor: BAILEY RONALD E
IPC: C22C38/00
Filed: 2014-06-05
Abstract: Abstract A process for making an alloy article comprising: austenitizing an alloy article by heating the alloy article in a furnace operating at a temperature of at least 1450F, the alloy comprising, in weight percentages based on total alloy weight: 0.40 to 0.53 carbon; 0.15 to 1.00 manganese; 0.15 to 0.45 silicon; 0.95 to 1.70 chromium; 3.30 to 4.30 nickel; 0.35 to 0.65 molybdenum; 0.0002 to 0.0050 boron; 0.001 to 0.015 cerium; 0.001 to 0.015 lanthanum; no greater than 0.002 sulfur; no greater than 0.015 phosphorus; no greater than 0.011 nitrogen; iron; and incidental impurities; cooling the alloy article from the austenitizing temperature in still air; and tempering the alloy article at a temperature of 250F to 500F for 450 minutes to 650 minutes time-at-temperature to provide a tempered alloy article; wherein the process does not comprise a liquid quench between the cooling and the tempering. 00)0C wI I,, I, i __6 LO L to -) lr Rd *1 --
Patent AU-2014212083-A1 (AU)
Title: System and method of applying carbon dioxide during the production of concrete
Inventor: LEE MICHAEL
IPC: B01F23/30
Filed: 2014-02-03
Abstract: The present disclosure involves systems and methods for applying CO2 to concrete, which may be performed in-situ or through a separate, stand-alone process. According to another embodiment disclosed herein, a system and method for applying CO2 to one or more materials used in the production of concrete is also provided.
Patent AU-2014218110-A1 (AU)
Title: Pharmaceutical compositions containing dexketoprofen and tramadol
Inventor: SCHMITZ REINHARD
IPC: A61K31/192
Filed: 2014-02-06
Abstract: A pharmaceutical composition as a solid oral dosage form is described, comprising: i) a combination of two pharmacological active principles, dexketoprofen salt with an organic or inorganic base and tramadol salt with an organic or inorganic acid, wherein: - the organic or inorganic base is selected in the group: trometamol, trimethylamine, dimethylamine, ethylamine, triethylamine, diethylamine, L-lysine, L-arginine, diethanolamine, sodium hydroxide, calcium hydroxide - the organic or inorganic acid is selected in the group: hydrochloric, hydrobromic, phosphoric, sulfuric, methanesulfonic, benzenesulfonic, toluenesulfonic, acetic, propionic, malic, maleic, succinic, citric, L-tartaric, lactic, malonic, aspartic, glutamic; ii) microcrystalline cellulose as a filler; iii) a binder selected in the group: maize starch,pre-gelatinised maize starch, hypromellose or their mixtures; iv) pharmaceutically acceptable excipients.
Patent AU-2014218931-A1 (AU)
Title: Genetic modification of rats
Inventor: LEE JEFFREY D
IPC: C12N5/10
Filed: 2014-02-20
Abstract: Compositions and methods are provided for making rat pluripotent and totipotent cells, including rat embryonic stem (ES) cells. Compositions and methods for improving efficiency or frequency of germline transmission of genetic modifications in rats are provided. Such methods and compositions comprise an
Patent AU-2014229281-A1 (AU)
Title: Use of tricarboxylic acid (TCA) intermediates to control ammonia generation in cell culture
Inventor: LARA-VELASCO OSCAR
IPC: C12P21/00
Filed: 2014-03-13
Abstract: The present invention is directed to a method of reducing the ammonium ion concentration in a mammalian cell culture, a method of maintaining or increasing cell productivity in a mammalian cell culture, a method of maintaining or increasing cell growth in a mammalian cell culture, and a method of reducing the influence of ammonium ion accumulation on antibody glycosylation patterns in a cell culture, comprising steps of growing the cells in a cell culture medium, and contacting or administering an effective amount of a TCA intermediate composition to the cell culture medium.
Patent AU-2014230916-A1 (AU)
Title: Energy efficient system and process for treating sludge
Inventor: HOJSGAARD SOREN JOHANNES
IPC: C02F11/12
Filed: 2014-03-10
Abstract: Apparatus and process is provided for hydrolyzing sludge from water treatment and for conditioning the hydrolyzed sludge for optimal anaerobic digestion. Methods provided include dewatering to produce dewatered sludge, hydrolyzing the dewatered sludge in a steam fed process, preheating the dewatered sludge before hydrolysis with sludge-to-sludge heat transfer, and cooling and diluting the sludge using sludge-to-water heat transfer and water injection, and anaerobically digesting the hydrolyzed sludge. Apparatus provided includes a generally vertically oriented counterflow sludge-to-sludge heat exchanger, a hydrolysis reactor and associated source of steam, sludge-to-water heat exchangers, and a dilution unit. Temperature and pressure sensors are configured to command various variable flow pumps and valves for controlling the process.
Patent AU-2014247462-A1 (AU)
Title: Duodenal internal covering membrane
Inventor: WAN PING
IPC: A61B17/00
Filed: 2014-03-28
Abstract: A duodenal internal covering membrane obtained from a biocompatible material consists primarily of a flexible ampulla portion (1) and a tubular portion (2); the ampulla (1) is positioned in the duodenal bulb and the tubular portion (2) can extend into the jejunum; the ampulla (1) includes a continuous elastic ring (3) which may be wave-shaped, V-shaped, stepped or crenellated, and may be of a shape-memory or non-shape-memory biocompatible material; the return angles at the peaks and troughs of the elastic ring (3) form single-loop springs (4) and are provided with anchoring hooks (5); the single-loop springs (4) at the lower edge loop around a recovery line (6); the upper edge of the ampulla (1) may be a wave-shaped, V-shaped, stepped or crenellated elastic membrane; the elastic ring (3) and ampulla (1) as a whole move in concert with the duodenum and duodenal bulb; when outside the body, the ampulla portion (1) and tubular portion (2) can be drawn in together, or folded into a spherical, tubular, capsular or spindle shape. The single-loop springs (4) are highly flexible, avoiding injury due to sharpness, and attach well to the recovery line (6) provided on them, and favour the anatomical structure and basic physiological functions of the duodenum. The present duodenal internal covering membrane can be prepared as a medical device to prevent obesity and diabetes.
Patent AU-2014259880-A1 (AU)
Title: Roll assemblies including superhard inserts, high pressure grinder roll apparatuses using same, and methods of use
Inventor: DANIELS GRANT KYLE
IPC: B02C4/02
Filed: 2014-04-30
Abstract: Embodiments of the invention are directed to roll assemblies configured to exhibit improved wear resistance of stud elements. Accordingly, the roll assemblies of may improve and/or increase the useful life of high pressure grinding roll apparatuses. In an embodiment, one or more stud elements (120) may include superhard material, which may provide superior wear resistance characteristics and may increase the useful life of the rolls assemblies (100) and high pressure grinding roll apparatuses.
Patent AU-2014276932-A1 (AU)
Title: Cytotoxic substance for use in combination with radiotherapy in cancer treatment
Inventor: DJONOV VALENTIN
IPC: A61K31/495
Filed: 2014-06-04
Abstract: The present invention provides a substance comprising a preparation of at least one chemotherapeutic or cytotoxic substance for the use in treatment of a disease of a mammalian patient, especially in the treatment of cancer. The invention suggests a symbiotic or synergistic combination of radiotherapy and chemotherapeutic or cytotoxic drug delivery.
Patent AU-2014298182-A1 (AU)
Title: A valve which depressurises, and a valve system
Inventor: TAYLOR JAY KENDALL
IPC: F16K99/00
Filed: 2014-07-28
Abstract: A valve for a fluidic cartridge is provided. The valve comprises a valve cavity having first and second openings connected to first and second passageways, respectively; and a flexible membrane within the valve cavity, the flexible membrane having a first portion actuatable to seal against the first opening and a second portion actuatable to seal against the second opening; wherein the valve cavity is configured such that the first flexible membrane portion may be actuated independently of the second flexible membrane portion to enable the first opening to be sealed independently of the second.
Patent AU-2014299916-A1 (AU)
Title: Therapeutic agent comprising humanized anti-Epiregulin antibody as active ingredient for non-small-cell lung carcinoma excluding adenocarcinoma
Inventor: SUZUKI MASAMI
IPC: A61P43/00
Filed: 2014-06-23
Abstract: The present inventors succeeded in producing: an anti-Epiregulin antibody exhibiting a cross-species reactivity between a non-human animal crab-eating monkey and a human animal; an anti-Epiregulin antibody with suppressed chemical decomposition; an anti-Epiregulin antibody having a lowered isoelectric point; an anti-Epiregulin antibody having an elevated thermal denaturation midpoint temperature; and an anti-Epiregulin antibody having a reduced amount of aggregates, by appropriately substituting an amino acid residue in the variable region sequence of a humanized EP27 antibody that is capable of exhibiting a cytotoxic activity and neutralization activity on a cancer cell, said cancer cell expressing human Epiregulin, to thereby inhibit the proliferation of the cancer cell. Also, the present inventors succeeded in creating a therapeutic agent for non-small-cell lung carcinoma excluding adenocarcinoma, said therapeutic agent comprising one of the aforesaid antibodies as an active ingredient.
Patent AU-2014302296-A1 (AU)
Title: Seed-origin endophyte populations, compositions, and methods of use
Inventor: VON MALTZAHN GEOFFREY
IPC: A01C1/06
Filed: 2014-06-26
Abstract: This application relates to methods and materials for providing a benefit to a seed or seedling of an agricultural plant (e.g., an agricultural grass plant), or the agricultural plant derived from the seed or seedling. For example, this application provides purified bacterial populations that include novel seed-origin bacterial endophytes, and synthetic combinations of seeds and/or seedlings (e.g., cereal seeds and/or seedlings) with heterologous seed-derived bacterial endophytes.
Patent AU-2014336052-A1 (AU)
Title: Method for determining high-mannose glycans
Inventor: OLSSON FREDRIK
IPC: G01N33/68
Filed: 2014-10-17
Abstract: The present invention relates to methods for analysing molecules comprising immunoglobulin Fc regions for the presence or absence of high-mannose glycans, and to for carrying out such methods.
Patent AU-2014351019-A1 (AU)
Title: Modular PDF application
Inventor: TUZLUKOV IGOR
IPC: G06F9/445
Filed: 2014-11-12
Abstract: A modular PDF application which allows users to customize their own PDF versions by choosing the features that they need and/or can pay for, thus, reducing the price of such PDF license and an overall footprint of such PDF version on the computer. The PDF application comprises a main application which includes the reader and a variety of optional features that the user may chose from and add to the main application before during or after installing the main application. The main application comprises business logic for running the viewer module and for receiving and running the optional features. The business logic includes inter-dependability rules and functions between the different features to ensure an optimum operability of the installed features in the presence or absence of the other features that they depend on.
Patent AU-2014378324-A1 (AU)
Title: Bag making and packaging machine
Inventor: YASUDA TAKAHIRO
IPC: B65B61/10
Filed: 2014-12-08
Abstract: Provided is bag manufacturing and packaging equipment that separates each bag by way of a pair of sealing members, with a blade mounted on the sealing members, cutting a lateral sealed portion by using the pressing pressure to sandwich a film during lateral sealing and that is capable of discharging bags continuously. A bag manufacturing and packaging equipment that manufactures a bag from film and packages an article inside the bag comprises a pair of sealing jaws (51), a knife, a pressing mechanism (56), and a pressing mechanism control unit. The sealing jaws laterally seal the film. The knife is mounted to one of the sealing jaws (51b) and melts and cuts the film lateral sealed portion. The pressing mechanism applies a pressing force to one of the sealing jaws (51a) in opposition to the other sealing jaw (51b) so that the pair of sealing jaws laterally seals the film by sandwiching the same therebetween, brings the knife into contact with the laterally sealed portion, and melts and cuts the laterally sealed portion. The pressing mechanism control unit stops applying the pressing force to the pressing mechanism on the basis of error information concerning the film or the article.
Patent AU-2015200204-A1 (AU)
Title: Data gathering system
Inventor: ZDEBLICK MARK
IPC: A61B5/0408
Filed: 2015-01-16
Abstract: Abstract A device for gathering data has first and second electrodes. The first electrode is coupled to a surface of interest, and the second electrode is coupled to "everything else" or "the air". The first electrode is shielded from the second, and from most sources of parasitic capacitance, by a shield that is driven by an active driver that drives the shield to track, and ideally to match, the instantaneous potential of the electrode. The second electrode is likewise shielded in a similar way from most sources of parasitic capacitance. These shields likewise help to limit the extent to which RFI from the device electronics couples with either of the electrodes. In this way the sensing device achieves a markedly better signal-to-noise ratio at frequency bands of interest. 108 103 102 Prior Art /-204 209-.E| 104\ 301 303 106 307 3708 309 103-, 302 305 105-' 36
Patent AU-2015200901-A1 (AU)
Title: Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
Inventor: TORRES VICTOR J
IPC: A61P17/00
Filed: 2015-02-23
Abstract: Disclosed herein are isolated and purified Staphylococcus aureus bi-component leukocidin, referred to herein as LukAB, and its components LukA and LukB, antibodies specific to LukA, antibodies specific to LukB, therapeutic compositions containing LukA and/or LukB, or anti-LukA and/or anti-LukB antibodies, uses of the compositions to treat acute inflammatory conditions or S. aureus infection, methods for identifying inhibitors of LukAB-mediated cytotoxicity of human phagocytes, and methods for using LukAB as a marker to predict severity of S. aureus infection.
Patent AU-2015201301-A1 (AU)
Title: Systems Methods and Apparatuses for Rehabilitation of Auditory System Disorders
Inventor: HANLEY PETER JOHN
IPC: H04R25/00
Filed: 2015-03-12
Abstract: Systems, methods and apparatuses for auditory system disorder rehabilitation by providing a stimulus to the auditory system of an individual experiencing an auditory disorder, tinnitus, conditions of reduced tolerance of loud sounds, or combinations thereof comprising, for example, a playback device and a method and apparatus for modifying an audio signal. The methods may include allowing a user to select an audio source (for example, a music track or the audio output of a television program) and modifying the audio with a spectral modified signal to create a spectrally modified audio. The spectrally modified audio can then be output by the playback device or other means for listening by the user. -53- aiB I o RASPL + LWTP1 ' RWTP1 -20 0 1000 10000 FREQ (Hz) PEAK MUSIC SPECTRA HEARING LOSS
Patent AU-2015203526-A1 (AU)
Title: Temperature monitoring return electrode
Inventor: GRESHBACK DAVID
IPC: A61B18/14
Filed: 2015-06-25
Abstract: An electrosurgical return electrode (6) is disclosed. The return electrode includes a return electrode pad (30) having a patient-contacting surface (32) configured to conduct electrosurgical energy and a ferromagnetic material layer (82) disposed on the return electrode pad (30), the ferromagnetic material layer (82) having a plurality of temperature sensing switches (84), the 0 ferromagnetic material layer (82) configured to undergo a change in a magnetic flux at a predetermined temperature threshold to actuate the plurality of temperature sensing switches (84).
Patent AU-2015218605-A1 (AU)
Title: EAS pulse transmission synchronization
Inventor: ALICOT JORGE F
IPC: G08B13/24
Filed: 2015-02-24
Abstract: Interference in an electronic article surveillance (EAS) system is reduced by transmitting warning pulse at a predetermined time following the EAS marker exciter pulse. The predetermined time and duration of the warning pulse are chosen so that the warning pulse acts upon a noise interference avoidance process in a second non-cooperative EAS unit. More particularly, the warning electromagnetic pulse causes a timing change in a second synchronized electromagnetic exciter pulse produced by the second EAS unit when the second synchronized electromagnetic, exciter pulse is concurrent with the first receive interval. This timing change causes the second EAS unit to no longer interfere with the first EAS unit.
Patent AU-2015218816-A1 (AU)
Title: De-centralized control architecture for accelerometer-based gravity gradiometers
Inventor: MEYER THOMAS J
IPC: G01V7/00
Filed: 2015-02-20
Abstract: A method for rebalancing a group of accelerometers in a gravity gradiometer instrument (GGI) includes the steps of defining and implementing a number of group- wise actuation constrainment modes based on a design of the gravity gradiometer instrument and its accelerometers. Implementing one constrainment mode comprises differentially scaling and distributing a single electrical current to multiple accelerometers' rebalance circuitry to cancel a specific acceleration effect experienced by the group of accelerometers or gradiometer as a whole. Superposition of a number of such modes enables rebalancing the full acceleration environment experienced by the group of accelerometers, given negligible local differential acceleration effects specific to, say, an individual accelerometer of the assembly. Mathematically, the multiple of constrainment modes are encapsulated by an actuation or constrainment modes matrix, arranged one mode per column of the matrix, and the electrical currents of respective modes are encapsulated in a vector listing of currents.
Patent AU-2015230864-A1 (AU)
Title: Method for measuring concentration of dissolved organic nitrogen of secondary effluent
Inventor: REN HONGQIANG
IPC: C02F3/02
Filed: 2015-09-28
Abstract: METHOD FOR MEASURING CONCENTRATION OF DISSOLVED ORGANIC NITROGEN OF SECONDARY EFFLUENT The invention discloses a method for measuring a concentration of DON of a secondary effluent, which belongs to the field of municipal sewage treatment. The method includes: charting the standard curve, establishing the mathematical model, and measuring the concentration of the DON in the secondary effluent. Based on establishment of the mathematical model among the concentration of the DON in the sewage and the contents of the protein and the HA therein, the concentration of the DON in the secondary effluent is calculated by the directly measured contents of the protein and the HA therein, and besides the constituents of the DON are provided, which reflects the treating effect of the wastewater treatment plant. The method of the invention features in accurate measurement, convenient operation, and strong applicability. ct) 'Co.~ cl ctf -o ct ot *~C 0 - o c - 0 - ~ I)~ * _ _ _ _ _ _ -ct --- J L -j - -- -----------------------------------e- ------
Patent AU-2015255269-A1 (AU)
Title: Compositions and Methods for Controlling Weeds in Crops
Inventor: LONG MITCHELL
IPC: A01N37/38
Filed: 2015-11-12
Abstract: Compositions and methods for controlling volunteer crop weeds in a crop by applying to weeds a herbicidally effective amount of a synergistic herbicidal composition that includes bromoxynil and a protoporphyrinogen oxidase (PPO) inhibitor are disclosed.
Patent AU-2015275926-A1 (AU)
Title: Oral composition of anti-TNF alpha antibodies
Inventor: CHTOUROU ABDESSATAR SAMI
IPC: C07K16/24
Filed: 2015-06-18
Abstract: The present invention relates to a pharmaceutical composition for oral delivery, including an anti tumour necrosis factor alpha (TNFα) antibody, preferably a monoclonal antibody produced in the milk of a transgenic non-human animal, and which can be combined advantageously with caprylic acid, and is preferably in a form that is suitable for targeted release of the antibody in the intestine.